GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $607,000 | -6.0% | 13,948 | -5.9% | 0.03% | +10.0% |
Q1 2022 | $646,000 | -4.7% | 14,826 | -3.5% | 0.03% | +3.4% |
Q4 2021 | $678,000 | +17.1% | 15,370 | +1.5% | 0.03% | +7.4% |
Q3 2021 | $579,000 | -46.3% | 15,148 | -44.0% | 0.03% | -47.1% |
Q2 2021 | $1,078,000 | +27.7% | 27,070 | +14.5% | 0.05% | +8.5% |
Q1 2021 | $844,000 | -39.4% | 23,651 | -37.5% | 0.05% | -61.5% |
Q4 2020 | $1,393,000 | -14.3% | 37,843 | -12.4% | 0.12% | -21.8% |
Q3 2020 | $1,626,000 | -10.7% | 43,197 | -3.2% | 0.16% | -9.3% |
Q2 2020 | $1,820,000 | +2.2% | 44,616 | -5.0% | 0.17% | -18.9% |
Q1 2020 | $1,780,000 | -25.9% | 46,977 | -8.1% | 0.21% | -0.5% |
Q4 2019 | $2,402,000 | +7.5% | 51,116 | -2.4% | 0.21% | -2.7% |
Q3 2019 | $2,235,000 | +3.1% | 52,378 | -3.3% | 0.22% | +0.5% |
Q2 2019 | $2,168,000 | +8.7% | 54,165 | +13.5% | 0.22% | +1.9% |
Q1 2019 | $1,994,000 | +13.6% | 47,722 | +3.9% | 0.21% | -4.5% |
Q4 2018 | $1,755,000 | -8.7% | 45,927 | -4.0% | 0.22% | +2.8% |
Q3 2018 | $1,923,000 | -0.9% | 47,860 | -0.5% | 0.22% | -9.5% |
Q2 2018 | $1,940,000 | +2.9% | 48,117 | -0.3% | 0.24% | -2.0% |
Q1 2018 | $1,885,000 | +91.2% | 48,249 | +73.7% | 0.25% | +105.0% |
Q4 2017 | $986,000 | -24.1% | 27,785 | -13.2% | 0.12% | -29.0% |
Q3 2017 | $1,299,000 | -27.7% | 31,998 | -23.2% | 0.17% | -27.5% |
Q2 2017 | $1,796,000 | +33.9% | 41,657 | +31.0% | 0.23% | +28.0% |
Q1 2017 | $1,341,000 | +13.2% | 31,809 | +3.3% | 0.18% | +4.0% |
Q4 2016 | $1,185,000 | -2.5% | 30,783 | +9.3% | 0.18% | -3.3% |
Q3 2016 | $1,215,000 | +13.8% | 28,167 | +14.3% | 0.18% | +3.4% |
Q2 2016 | $1,068,000 | +18.3% | 24,649 | +10.7% | 0.18% | +11.5% |
Q1 2016 | $903,000 | +6.2% | 22,269 | +5.8% | 0.16% | +1.9% |
Q4 2015 | $850,000 | +12.0% | 21,054 | +6.7% | 0.15% | +1.3% |
Q3 2015 | $759,000 | -15.4% | 19,739 | -8.3% | 0.15% | -8.4% |
Q2 2015 | $897,000 | +9.4% | 21,526 | +21.1% | 0.17% | +19.4% |
Q1 2015 | $820,000 | +0.5% | 17,770 | -7.0% | 0.14% | +11.2% |
Q4 2014 | $816,000 | -7.6% | 19,098 | -0.6% | 0.12% | -8.8% |
Q3 2014 | $883,000 | +4.1% | 19,216 | +21.2% | 0.14% | +1.5% |
Q2 2014 | $848,000 | +19.1% | 15,850 | +19.0% | 0.14% | +8.0% |
Q1 2014 | $712,000 | +16.7% | 13,320 | +16.5% | 0.12% | -13.2% |
Q4 2013 | $610,000 | -4.5% | 11,430 | -10.2% | 0.14% | -14.8% |
Q3 2013 | $639,000 | -19.7% | 12,729 | -20.1% | 0.17% | -22.5% |
Q2 2013 | $796,000 | – | 15,924 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |